UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063488
Receipt number R000072617
Scientific Title Diagnostic Accuracy of Flow-Limited Tidal Pressure-Volume Loops for Detecting Tidal Derecruitment in Mechanically Ventilated Patients
Date of disclosure of the study information 2026/11/01
Last modified on 2026/11/01 17:28:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Diagnostic Accuracy of Flow-Limited Tidal Pressure-Volume Loops for Detecting Tidal Derecruitment in Mechanically Ventilated Patients

Acronym

PV Loop Derecruitment Study

Scientific Title

Diagnostic Accuracy of Flow-Limited Tidal Pressure-Volume Loops for Detecting Tidal Derecruitment in Mechanically Ventilated Patients

Scientific Title:Acronym

PV Loop Derecruitment Study

Region

Japan


Condition

Condition

Respiratory failure

Classification by specialty

Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

During a decremental PEEP trial, tidal pressure-volume loops are recorded with inspiratory flow limited to 2 and 5 L/min. In stage 1, regional pressure-impedance relationships measured by electrical impedance tomography (EIT) are used to identify findings indicating tidal recruitment/derecruitment. In stage 2, using these EIT findings as the reference, the ability of global tidal hysteresis at 2 L/min and 5 L/min to detect tidal recruitment/derecruitment is compared.

Basic objectives2

Others

Basic objectives -Others

Validity and detection performance of physiological indices

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Stage 1: whether the prespecified primary hypotheses in the statistical analysis plan are supported (PEEP dependence of EIT findings of tidal recruitment/derecruitment and their agreement with independent physiological indices). Stage 2: detection performance (sensitivity, specificity, AUC) of global tidal hysteresis at 2 L/min versus 5 L/min, using the EIT findings as the reference.

Key secondary outcomes

(1) Difference in hysteresis between the two flow conditions, and hysteresis normalized to predicted body weight. (2) Agreement of the pressure at linearization point (PLP) between conditions. (3) Knee point in the hysteresis trend during PEEP decrement. (4) Relationship between inspiratory stress rate and hysteresis. (5) Sensitivity analysis using the Mojoli 2026 threshold (1.4 mL/kg). (6) Detection accuracy against a decrease in respiratory system compliance of 1 mL/cmH2O or more per 2 cmH2O PEEP decrement. (7) Repeatability of measurements repeated under identical conditions. (8) Reversibility of regional indices at the PEEP set after the trial. (9) PEEP dependence of regional EIT indices (layer hysteresis, delta EELI, regional ventilation delay, silent spaces). (10) Presence and flow dependence of the inspiratory uncorking effect.


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment



Intervention

No. of arms

2

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Odd-numbered participants (by order of consent): at each PEEP step, tidal PV loops are recorded in the order 2, 5, 2, 5 L/min inspiratory flow. The decremental PEEP trial starts at 20 cmH2O in patients judged recruitable by the recruitment-to-inflation ratio and at 14 cmH2O otherwise, decreasing by 2 cmH2O to 8 cmH2O, with at least 3 minutes at each step and simultaneous EIT recording. Loops at both flows are also recorded at the PEEP set after the trial.

Interventions/Control_2

Even-numbered participants: same as intervention 1, but in the order 5, 2, 5, 2 L/min.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Age 18 years or older. (2) Receiving invasive mechanical ventilation. (3) Current PEEP of 8 cmH2O or higher. (4) Ventilated in pressure-controlled assist-control mode. (5) Passive ventilation or equivalent conditions allowing assessment. (6) Judged eligible for the maneuver by the principal investigator or attending physician. (7) Written informed consent from the patient or a legally authorized representative.

Key exclusion criteria

(1) Strong spontaneous breathing (P0.1 of 3 cmH2O or higher). (2) Large circuit leak (leak fraction above 20%). (3) Pneumothorax, bronchopleural fistula, or other conditions making interpretation of respiratory mechanics difficult. (4) Severe hemodynamic instability, such as increasing vasopressor dose. (5) Severe intracranial hypertension. (6) Any other condition judged inappropriate by the principal investigator or attending physician.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Satoshi
Middle name
Last name Kazuma

Organization

Sapporo Medical University

Division name

Department of Intensive Care Medicine

Zip code

060-8556

Address

South 1, West 17, Chuo-ku, Sapporo, Hokkaido, Japan

TEL

011-611-2111

Email

b_days@msn.com


Public contact

Name of contact person

1st name Yuya
Middle name
Last name Goto

Organization

Sapporo Medical University

Division name

Department of Intensive Care Medicine

Zip code

0640805

Address

South 1, West 17, Chuo-ku, Sapporo, Hokkaido, Japan

TEL

09033963679

Homepage URL


Email

ygoto@sapmed.ac.jp


Sponsor or person

Institute

Sapporo Medical University

Institute

Department

Personal name

YUYA GOTO


Funding Source

Organization

Sapporo Medical University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Sapporo Medical University

Address

South 1, West 17, Chuo-ku, Sapporo, Hokkaido, Japan

Tel

011-611-2111

Email

ygoto@sapmed.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2026 Year 08 Month 13 Day

Date of IRB

2026 Year 08 Month 13 Day

Anticipated trial start date

2026 Year 11 Month 01 Day

Last follow-up date

2027 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 11 Month 01 Day

Last modified on

2026 Year 11 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072617